You would be happy with them dumping all of their cash on hand a rest of 2018 net profits on phase I clinical trial?
Let's agree to disagree. Terrible, terrible idea. You obviously dont know how many drugs are successful vs how many fail clinical trials. Please read up and prove me wrong.